- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/56 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Patent holdings for IPC class C07D 215/56
Total number of patents in this class: 287
10-year publication summary
|
27
|
32
|
15
|
26
|
19
|
13
|
11
|
16
|
13
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1568 |
45 |
| Bayer Animal Health GmbH | 230 |
9 |
| Vertex Pharmaceuticals (europe) Limited | 17 |
8 |
| Active Biotech AB | 62 |
8 |
| Japan Tobacco Inc. | 3488 |
8 |
| Gilead Sciences, Inc. | 1951 |
7 |
| Proteostasis Therapeutics, Inc. | 72 |
6 |
| City of Hope | 960 |
5 |
| Sunshine Lake Pharma Co., Ltd. | 570 |
5 |
| Allergan, Inc. | 2438 |
4 |
| California Institute of Technology | 3936 |
4 |
| Laurus Labs Limited | 99 |
4 |
| Boehringer Ingelheim International GmbH | 4754 |
3 |
| Takeda Pharmaceutical Company Limited | 2943 |
3 |
| Concert Pharmaceuticals, Inc. | 252 |
3 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1320 |
3 |
| Council of Scientific & Industrial Research | 1409 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1535 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
3 |
| Teva Pharmaceutical Industries Ltd. | 848 |
3 |
| Other owners | 150 |